ventrigel
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT02305602)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ventrigel
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06461676 | Phase 1 | Oct 1, 2024 | Emory University, University of California, San Diego, Ventrix, Inc. |
| NCT02305602 | Phase 1 | Sep 1, 2015 | Ventrix, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ventrix, Inc. | For profit | 2 | 1 | 1 | 2015 |
| Emory University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of California, San Diego | Academic/Hospital | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1